70.84

0.03% 0.02

Pre-market: 70.75 -0.09 -0.13%

Avidity Biosciences Inc (RNA)

Overview News Price History Option Chain Financials Discussions Forecast

Avidity Biosciences Inc stock is traded at $70.84, with a volume of 2.35M. It is up +0.03% in the last 24 hours and up +44.69% over the past month. Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Previous Close:

$70.82

Open:

$70.9

24h Volume:

2.35M

Relative Volume:

0.47

Market Cap:

$10.34B

Revenue:

$10.73M

Net Income/Loss:

$-455.74M

P/E Ratio:

-19.92

EPS:

-3.5569

Net Cash Flow:

$-502.70M

1W Performance:

+1.52%

1M Performance:

+44.69%

6M Performance:

+137.08%

1Y Performance:

+34.93%

1-Day Range:

$70.61

$70.95

1-Week Range:

$69.67

$70.98

52-Week Range:

$21.51

$72.05

Avidity Biosciences Inc Stock (RNA) Company Profile

Name

Avidity Biosciences Inc

Sector

Healthcare (1103)

Industry

Biotechnology (618)

Phone

858-401-7900

Address

3020 CALLAN ROAD, SAN DIEGO, CA

Employee

391

Twitter

Next Earnings Date

2024-12-07

Latest SEC Filings

RNA's Discussions on Twitter

Compare RNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RNA Avidity Biosciences Inc	70.84	10.67B	10.73M	-455.74M	-502.70M	-3.5569
VRTX Vertex Pharmaceuticals Inc	434.52	110.16B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	694.99	71.65B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	453.97	59.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	891.73	54.79B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	368.36	41.77B	4.98B	69.59M	525.67M	0.5197

Avidity Biosciences Inc Stock (RNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-17-25	Initiated	Roth Capital	Buy
Jul-10-25	Resumed	Goldman	Buy
Jun-24-25	Initiated	Bernstein	Outperform
Jun-17-25	Initiated	Wolfe Research	Outperform
Jun-11-25	Initiated	Raymond James	Strong Buy
Mar-13-25	Initiated	Citigroup	Buy
Mar-12-25	Initiated	BMO Capital Markets	Outperform
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Dec-20-24	Initiated	H.C. Wainwright	Buy
Nov-26-24	Initiated	RBC Capital Mkts	Outperform
Sep-24-24	Initiated	Goldman	Buy
Aug-28-24	Initiated	Barclays	Overweight
May-03-24	Initiated	BofA Securities	Buy
Mar-14-24	Initiated	Cantor Fitzgerald	Overweight
May-22-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-31-23	Downgrade	Evercore ISI	Outperform → In-line
Jul-20-22	Initiated	Chardan Capital Markets	Buy
Jul-12-22	Initiated	Raymond James	Strong Buy
Sep-07-21	Initiated	Evercore ISI	Outperform
Jun-17-21	Initiated	Needham	Buy
Apr-26-21	Resumed	Credit Suisse	Outperform
Jul-07-20	Initiated	Cowen	Outperform
Jul-07-20	Initiated	Credit Suisse	Outperform
Jul-07-20	Initiated	SVB Leerink	Outperform
Jul-07-20	Initiated	Wells Fargo	Overweight

View All

Avidity Biosciences Inc Stock (RNA) Latest News

01:51 AM

Detecting support and resistance levels for Avidity Biosciences Inc.Trade Risk Assessment & Free High Return Stock Watch Alerts - newser.com

01:51 AM

01:22 AM

Price action breakdown for Avidity Biosciences Inc.Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com

01:22 AM

Nov 13, 2025

Visual analytics tools that track Avidity Biosciences Inc. performanceJuly 2025 Setups & Safe Capital Allocation Plans - newser.com

Nov 13, 2025

Is Avidity Biosciences Inc. showing signs of accumulationPortfolio Growth Summary & Weekly Breakout Watchlists - newser.com

Nov 13, 2025

Will Avidity Biosciences Inc. stock attract more institutional investorsVolume Spike & Technical Pattern Alert System - newser.com

Nov 13, 2025

Using AI based signals to follow Avidity Biosciences Inc.July 2025 Analyst Calls & Growth Focused Investment Plans - newser.com

Nov 13, 2025

What to expect from Avidity Biosciences Inc. in the next 30 daysWatch List & AI Driven Stock Price Forecasts - newser.com

Nov 13, 2025

Risk adjusted return profile for Avidity Biosciences Inc. analyzedQuarterly Profit Review & Weekly Breakout Stock Alerts - newser.com

Nov 13, 2025

Heatmap analysis for Avidity Biosciences Inc. and competitorsTrade Risk Report & Safe Entry Point Identification - newser.com

Nov 13, 2025

Can Avidity Biosciences Inc. stock deliver sustainable ROEJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com

Nov 13, 2025

Nov 12, 2025

Short interest data insights for Avidity Biosciences Inc.Jobs Report & Expert Curated Trade Setups - newser.com

Nov 12, 2025

Avidity Biosciences stock reaches all-time high at 70.52 USD By Investing.com - Investing.com Nigeria

Nov 12, 2025

Why Avidity Biosciences Inc. stock attracts global investorsOptions Play & Technical Pattern Alert System - newser.com

Nov 12, 2025

Nov 11, 2025

Will Avidity Biosciences Inc. stock deliver long term returns2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com

Nov 11, 2025

Chardan Capital Maintains Avidity Biosciences (RNA) Neutral Recommendation - Nasdaq

Nov 11, 2025

Avidity Biosciences stock reaches all-time high at 70.52 USD - Investing.com

Nov 11, 2025

Earnings visualization tools for Avidity Biosciences Inc.Quarterly Market Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 11, 2025

Should Doubling of Net Losses in Q3 Require Action From Avidity Biosciences (RNA) Investors? - simplywall.st

Nov 11, 2025

Applying Wyckoff theory to Avidity Biosciences Inc. stockQuarterly Growth Report & Real-Time Volume Spike Alerts - newser.com

Nov 11, 2025